Increasing Government Initiatives Upsurges the Growth of the Global Liquid Biopsy Market at 22.97% of CAGR by 2026

BOSTON, June 6, 2018 (Newswire.com) - Browse 34 market data Tables and 66 Figures spread through 276 Pages and in-depth analysis on “Global Liquid Biopsy Market by Products (CTCS and CTDNA and Exosome) by Analysis Purpose (Early Detection/screening, Therapy Guidance, Monitoring  & Diagnosis) by End User (Hysician’s ‘office Laboratories’, Hospitals & Clinical Diagnostic Laboratories) by Analysis Platform (Ngs, Microarray, Pcr, Proteomics & Other Analysis Platform) by Biomarker Types (Nucleic Acids, Proteins, Extracellular Vesicles & Cells) by Indication (Nipt, Cancer & Transplant) market by Geography- Regional Trends & Forecast to 2026.”

This insightful market research report from Inkwood Research focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, and Rest of World, the report is a valuable asset for the existing players, new entrants, and the future investors. The study presents detailed market analysis with inputs derived from industry professionals across the value chain.

The Global Liquid Biopsy market was valued at nearly 740 million in 2017 and is anticipated to reach around $ 4740 million by 2026, growing at an estimated CAGR of 22.97%, during the forecast period 2018-2026.

clive cooper, Corporate Communications

Liquid Biopsy market scenario

Rising government initiatives, growing pervasiveness of cancer cases in the older populace, growing number of diagnostic centers, the growth of precision medicine & emergence of tissue/tumor-agnostic drugs are the reasons advancing the growth of the global Liquid Biopsy market.

The Liquid Biopsy Market report provides data tables, includes charts and graphs for visual analysis.

Request Free Sample Report for Global Liquid Biopsy Market by Products, Analysis Purpose, End Use, Analysis Platform, Biomarker Types, Indication & Geography. https://www.inkwoodresearch.com/reports/global-liquid-biopsy-market-forecast-2018-2026/#request-free-sample

Market Segmentation

On the basis of Products, the Global Liquid Biopsy Market is segmented as follows:

• CTCS AND CTDNA
• Exosome

On the basis of Analysis Purpose, the Global Liquid Biopsy Market is segmented as follows:

• Early detection/screening
• Therapy guidance
• Monitoring
• Diagnosis

On the basis of End User, the Global Liquid Biopsy Market is segmented as follows:

• PHYSICIAN’S ‘OFFICE LABORATORIES’
• HOSPITALS
• CLINICAL DIAGNOSTIC LABORATORIES

On the basis of Analysis Platform, the Global Liquid Biopsy Market is segmented as follows:

• NGS
• Microarray
• PCR
• Proteomics
• Other Analysis Platform

On the basis of Biomarker Types, the Global Liquid Biopsy Market is segmented as follows:

• Nucleic Acids
• Proteins
• Extracellular Vesicles
• Cells

On the basis of Indication, the Global Liquid Biopsy Market is segmented as follows:

• NIPT
• Cancer
• Transplant

Report Highlights
- The report provides a detailed analysis of current and future market trends to identify the investment opportunities
- Market forecasts till 2026, using estimated market values as the base numbers
- Key market trends across the business segments, regions and countries
- Key developments and strategies observed in the market
- Market dynamics such as drivers, restraints, opportunities and other trends
- In-depth company profiles of key players and upcoming prominent players
- Growth prospects among the emerging nations through 2026

Companies Profiled

-        AD-TECH MEDICAL INSTRUMENT CORP

-        AGILENT TECHNOLOGIES, INC.

-        ARGON MEDICAL DEVICES INC

-        BRAUN MELSUNGEN AG

-        BECTON, DICKINSON

-        BOSTON SCIENTIFIC CORPORATION

-        BIO-RAD LABORATORIES, INC.

-        R. BARD, INC.

-        CINTEC MEDICAL LTD

-        COOK GROUP INC

-        FISCHER MEDICAL TECHNOLOGIES LLC

-        M.S. INTERNAZIONALE MEDICO SCIENTIFICA SRL

-        PLANMECA OY

-        ROCHE DIAGNOSTICS LTD

-        QIAGEN N.V.

Related Reports

Neuro Rehabilitation Device Market- Global Neuro Rehabilitation Device Market is anticipated to grow at a CAGR of 15.24% by 2026.

Bone Marrow Transplant Market- Global Bone Marrow Transplant Market is anticipated to grow at a CAGR of 5.45% by 2026.

Blood Plasma Market- Global Blood Plasma Market is anticipated to grow at a CAGR of 6.62% by 2026.

Internet of Things (IoT) in Healthcare Market- Global Internet of Things (IoT) in Healthcare market is anticipated to grow at CAGR of 29.09% by 2026

Source: Inkwood Research